Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes

Frontiers in Behavioral Neuroscience

Volumn 11, Issue , 2017, Pages

  De Bartolomeis, Andrea ^a   Buonaguro, Elisabetta F ^a   Latte, Gianmarco ^a   Rossi, Rodolfo ^a   Marmo, Federica ^a   Iasevoli, Felice ^a   Tomasetti, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Arc; BDNF; Bipolar disorders; Clozapine; Cognition; Haloperidol; Homer1a; Schizophrenia

Indexed keywords

AMISULPRIDE; ASENAPINE; CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; HALOPERIDOL; LURASIDONE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE;

ARC GENE; BDNF GENE; BRAIN REGION; COGNITION; EGR1 GENE; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; HOMER1A GENE; HUMAN; IMMEDIATE EARLY GENE; LEARNING; MEMORY; NARP GENE; NERVE CELL PLASTICITY; NONHUMAN; NPAS4 GENE; NUR GENE; ONCOGENE C FOS; ONCOGENE C JUN; PSYCHOSIS; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA;

EID: 85042001599     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2017.00240     Document Type: Review

References (265)

1. Ahmed, M. R., Gurevich, V. V., Dalby, K. N., Benovic, J. L., and Gurevich, E. V. (2008). Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation. J. Pharmacol. Exp. Ther. 325, 276–283. doi: 10.1124/jpet.107.131987
2. Aicardi, G., Argilli, E., Cappello, S., Santi, S., Riccio, M., Thoenen, H., et al. (2004). Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 101, 15788–15792. doi: 10.1073/pnas.0406960101
3. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., and Timmusk, T. (2007). Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85, 525–535. doi: 10.1002/jnr.21139
4. Alme, M. N., Wibrand, K., Dagestad, G., and Bramham, C. R. (2007). Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast. 2007:26496. doi: 10.1155/2007/26496
5. Alonso, M., Medina, J. H., and Pozzo-Miller, L. (2004). ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn. Mem. 11, 172–178. doi: 10.1101/lm.67804
6. Ambesi-Impiombato, A., Panariello, F., Dell’aversano, C., Tomasetti, C., Muscettola, G., and De Bartolomeis, A. (2007). Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain. Synapse 61, 429–439. doi: 10.1002/syn.20385
7. Amemori, K., Gibb, L. G., and Graybiel, A. M. (2011). Shifting responsibly: the importance of striatal modularity to reinforcement learning in uncertain environments. Front. Hum. Neurosci. 5:47. doi: 10.3389/fnhum.2011.00047
8. Amin, E., Pearce, J. M., Brown, M. W., and Aggleton, J. P. (2006). Novel temporal configurations of stimuli produce discrete changes in immediate-early gene expression in the rat hippocampus. Eur. J. Neurosci. 24, 2611–2621. doi: 10.1111/j.1460-9568.2006.05131.x
9. Ancin, I., Cabranes, J. A., Vazquez-Alvarez, B., Santos, J. L., Sanchez-Morla, E., Alaerts, M., et al. (2013). NR4A2: effects of an “orphan” receptor on sustained attention in a schizophrenic population. Schizophr. Bull. 39, 555–563. doi: 10.1093/schbul/sbr176
10. Angelucci, F., Mathe, A. A., and Aloe, L. (2000). Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J. Neurosci. Res. 60, 783–794. doi: 10.1002/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M
11. Atkins, J. B., Chlan-Fourney, J., Nye, H. E., Hiroi, N., Carlezon, W. A. Jr., and Nestler, E. J. (1999). Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse 33, 118–128. doi: 10.1002/(SICI)1098-2396(199908)33:2<118::AID-SYN2>3.0.CO;2-L
12. Backman, C., Perlmann, T., Wallen, A., Hoffer, B. J., and Morales, M. (1999). A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res. 851, 125–132. doi: 10.1016/S0006-8993(99)02149-6
13. Bai, O., Chlan-Fourney, J., Bowen, R., Keegan, D., and Li, X. M. (2003). Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J. Neurosci. Res. 71, 127–131. doi: 10.1002/jnr.10440
14. Balleine, B. W., and O’doherty, J. P. (2010). Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 35, 48–69. doi: 10.1038/npp.2009.131
15. Baquet, Z. C., Bickford, P. C., and Jones, K. R. (2005). Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J. Neurosci. 25, 6251–6259. doi: 10.1523/JNEUROSCI.4601-04.2005
16. Barnes, P., Kirtley, A., and Thomas, K. L. (2012). Quantitatively and qualitatively different cellular processes are engaged in CA1 during the consolidation and reconsolidation of contextual fear memory. Hippocampus 22, 149–171. doi: 10.1002/hipo.20879
17. Beaudry, G., Langlois, M. C., Weppe, I., Rouillard, C., and Levesque, D. (2000). Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J. Neurochem. 75, 1694–1702. doi: 10.1046/j.1471-4159.2000.0751694.x
18. Beckervordersandforth, R., Zhang, C. L., and Lie, D. C. (2015). Transcription-factor-dependent control of adult hippocampal neurogenesis. Cold Spring Harb. Perspect. Biol. 7:a018879. doi: 10.1101/cshperspect.a018879
19. Beckmann, A. M., and Wilce, P. A. (1997). Egr transcription factors in the nervous system. Neurochem. Int. 31, 477–510; discussion: 517–6. doi: 10.1016/S0197-0186(96)00136-2
20. Benedetti, F., Poletti, S., Locatelli, C., Mazza, E., Lorenzi, C., Vitali, A., et al. (2018). AHomer 1 gene variant influences brain structure and function, lithiumeffects on white matter, and antidepressant response in bipolar disorder: a multimodal genetic imaging study. Prog. Neuropsychopharmacol. Biol. Psychiatry 81, 88–95. doi: 10.1016/j.pnpbp.2017.10.011
21. Benito, E., and Barco, A. (2015). The neuronal activity-driven transcriptome. Mol. Neurobiol. 51, 1071–1088. doi: 10.1007/s12035-014-8772-z
22. Bepari, A. K., Sano, H., Tamamaki, N., Nambu, A., Tanaka, K. F., and Takebayashi, H. (2012). Identification of optogenetically activated striatal medium spiny neurons by Npas4 expression. PLoS ONE 7:e52783. doi: 10.1371/journal.pone.0052783
23. Bigio, B., Mathe, A. A., Sousa, V. C., Zelli, D., Svenningsson, P., McEwen, B. S., et al. (2016). Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: implications for treatment resistance. Proc. Natl. Acad. Sci. U.S.A. 113, 7906–7911. doi: 10.1073/pnas.1603111113
24. Bloomer, W. A., Vandongen, H. M., and Vandongen, A. M. (2008). Arc/Arg3.1 translation is controlled by convergent N-methyl-D-aspartate and Gs-coupled receptor signaling pathways. J. Biol. Chem. 283, 582–592. doi: 10.1074/jbc.M702451200
25. Bottai, D., Guzowski, J. F., Schwarz, M. K., Kang, S. H., Xiao, B., Lanahan, A., et al. (2002). Synaptic activity-induced conversion of intronic to exonic sequence in Homer 1 immediate early gene expression. J. Neurosci. 22, 167–175.
26. Bourhis, E., Maheux, J., Rouillard, C., and Levesque, D. (2008). Extracellular signal-regulated kinases (ERK) and protein kinase C (PKC) activities are involved in the modulation of Nur77 and Nor-1 expression by dopaminergic drugs. J. Neurochem. 106, 875–888. doi: 10.1111/j.1471-4159.2008.05455.x
27. Boyajyan, A., Zakharyan, R., Atshemyan, S., Chavushyan, A., and Mkrtchyan, G. (2015). Schizophrenia-associated risk and protective variants of c-Fos encoding gene. Recent Adv. DNA Gene Seq. 9, 51–57. doi: 10.2174/2352092209666150223113334
28. Bramham, C. R., Alme, M. N., Bittins, M., Kuipers, S. D., Nair, R. R., Pai, B., et al. (2010). The Arc of synaptic memory. Exp. Brain Res. 200, 125–140. doi: 10.1007/s00221-009-1959-2
29. Bubser, M., and Deutch, A. Y. (2002). Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum. Eur. J. Neurosci. 15, 713–720. doi: 10.1046/j.1460-9568.2002.01903.x
30. Buervenich, S., Carmine, A., Arvidsson, M., Xiang, F., Zhang, Z., Sydow, O., et al. (2000). NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am. J. Med. Genet. 96, 808–813. doi: 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E
31. Buonaguro, E. F., Iasevoli, F., Marmo, F., Eramo, A., Latte, G., Avagliano, C., et al. (2017a). Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: a putative link with synaptic remodeling. Prog. Neuropsychopharmacol. Biol. Psychiatry 76, 29–41. doi: 10.1016/j.pnpbp.2017.02.012
32. Buonaguro, E. F., Tomasetti, C., Chiodini, P., Marmo, F., Latte, G., Rossi, R., et al. (2017b). Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: implications for treatment resistant schizophrenia. J. Psychopharmacol. 31, 406–417. doi: 10.1177/0269881116658987.
33. Calabrese, F., Molteni, R., Gabriel, C., Mocaer, E., Racagni, G., and Riva, M. A. (2011). Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine. Psychopharmacology 215, 267–275. doi: 10.1007/s00213-010-2129-8
34. Campos-Melo, D., Galleguillos, D., Sanchez, N., Gysling, K., and Andres, M. E. (2013). Nur transcription factors in stress and addiction. Front. Mol. Neurosci. 6:44. doi: 10.3389/fnmol.2013.00044
35. Cannon, T. D., Chung, Y., He, G., Sun, D., Jacobson, A., Van Erp, T. G., et al. (2015). Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol. Psychiatry 77, 147–157. doi: 10.1016/j.biopsych.2014.05.023
36. Castner, S. A., Goldman-Rakic, P. S., and Williams, G. V. (2004). Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology 174, 111–125. doi: 10.1007/s00213-003-1710-9
37. Castren, E., Da Penha Berzaghi, M., Lindholm, D., and Thoenen, H. (1993). Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain. Exp. Neurol. 122, 244–252. doi: 10.1006/exnr.1993.1124
38. Chang, M. C., Park, J. M., Pelkey, K. A., Grabenstatter, H. L., Xu, D., Linden, D. J., et al. (2010). Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons. Nat. Neurosci. 13, 1090–1097. doi: 10.1038/nn.2621
39. Chen, Q. Y., Chen, Q., Feng, G. Y., Wan, C. L., Lindpaintner, K., Wang, L. J., et al. (2006). Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia inthe Chinese population. Neurosci. Lett. 397, 285–290. doi: 10.1016/j.neulet.2005.12.033
40. Chen, W. G., West, A. E., Tao, X., Corfas, G., Szentirmay, M. N., Sawadogo, M., et al. (2003). Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. J. Neurosci. 23, 2572–2581.
41. Chen, Z. Y., Patel, P. D., Sant, G., Meng, C. X., Teng, K. K., Hempstead, B. L., et al. (2004). Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 24, 4401–4411. doi: 10.1523/JNEUROSCI.0348-04.2004
42. Cheval, H., Chagneau, C., Levasseur, G., Veyrac, A., Faucon-Biguet, N., Laroche, S., et al. (2012). Distinctive features of Egr transcription factor regulation and DNA binding activity in CA1 of the hippocampus in synaptic plasticity and consolidation and reconsolidation of fear memory. Hippocampus 22, 631–642. doi: 10.1002/hipo.20926
43. Chlan-Fourney, J., Ashe, P., Nylen, K., Juorio, A. V., and Li, X. M. (2002). Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Res. 954, 11–20. doi: 10.1016/S0006-8993(02)03215-8
44. Chowdhury, S., Shepherd, J. D., Okuno, H., Lyford, G., Petralia, R. S., Plath, N., et al. (2006). Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 52, 445–459. doi: 10.1016/j.neuron.2006.08.033
45. Cochran, S. M., McKerchar, C. E., Morris, B. J., and Pratt, J. A. (2002). Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol. Neuropharmacology 43, 394–407. doi: 10.1016/S0028-3908(02)00091-6
46. Collins, C. M., Wood, M. D., and Elliott, J. M. (2014). Chronic administration of haloperidol and clozapine induces differential effects on the expression of Arc and c-Fos in rat brain. J. Psychopharmacol. 28, 947–954. doi: 10.1177/0269881114536788
47. Coutellier, L., Beraki, S., Ardestani, P. M., Saw, N. L., and Shamloo, M. (2012). Npas4: a neuronal transcription factor with a key role in social and cognitive functions relevant to developmental disorders. PLoS ONE 7:e46604. doi: 10.1371/journal.pone.0046604
48. Dahl, J. P., Kampman, K. M., Oslin, D. W., Weller, A. E., Lohoff, F. W., Ferraro, T. N., et al. (2005). Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American population. Psychiatr. Genet. 15, 277–283. doi: 10.1097/00041444-200512000-00010
49. Daunais, J. B., and McGinty, J. F. (1996). The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Brain Res. Mol. Brain Res. 35, 237–248. doi: 10.1016/0169-328X(95)00226-I
50. Davis, S., Bozon, B., and Laroche, S. (2003). How necessary is the activation of the immediate early gene zif268 in synaptic plasticity and learning? Behav. Brain Res. 142, 17–30. doi: 10.1016/S0166-4328(02)00421-7
51. De Bartolomeis, A., Avvisati, L., Iasevoli, F., and Tomasetti, C. (2013a). Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment. Eur. J. Pharmacol. 718, 502–523. doi: 10.1016/j.ejphar.2013.06.034
52. De Bartolomeis, A., and Iasevoli, F. (2003). The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. Psychopharmacol. Bull. 37, 51–83.
53. De Bartolomeis, A., Iasevoli, F., Marmo, F., Buonaguro, E. F., Eramo, A., Rossi, R., et al. (2015a). Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment. Eur. Neuropsychopharmacol. 25, 566–582. doi: 10.1016/j.euroneuro.2015.01.003
54. De Bartolomeis, A., Latte, G., Tomasetti, C., and Iasevoli, F. (2014). Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. Mol. Neurobiol. 49, 484–511. doi: 10.1007/s12035-013-8534-3
55. De Bartolomeis, A., Marmo, F., Buonaguro, E. F., Latte, G., Tomasetti, C., and Iasevoli, F. (2016). Switching antipsychotics: imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naive vs. antipsychotic-exposed rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 70, 24–38. doi: 10.1016/j.pnpbp.2016.04.015
56. De Bartolomeis, A., Marmo, F., Buonaguro, E. F., Rossi, R., Tomasetti, C., and Iasevoli, F. (2013b). Imaging brain gene expression profiles by antipsychotics: region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol. Eur. Neuropsychopharmacol. 23, 1516–1529. doi: 10.1016/j.euroneuro.2012.11.014
57. De Bartolomeis, A., Tomasetti, C., Cicale, M., Yuan, P. X., and Manji, H. K. (2012). Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor. Eur. Neuropsychopharmacol. 22, 527–535. doi: 10.1016/j.euroneuro.2011.11.006
58. De Bartolomeis, A., Tomasetti, C., and Iasevoli, F. (2015b). Update on the mechanism of action of aripiprazole: translational insights into antipsychotic strategies beyond dopamine receptor antagonism. CNS Drugs 29, 773–799. doi: 10.1007/s40263-015-0278-3
59. De Foubert, G., Carney, S. L., Robinson, C. S., Destexhe, E. J., Tomlinson, R., Hicks, C. A., et al. (2004). Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128, 597–604. doi: 10.1016/j.neuroscience.2004.06.054
60. Dell’aversano, C., Tomasetti, C., Iasevoli, F., and De Bartolomeis, A. (2009). Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders. Brain Res. Bull. 79, 123–129. doi: 10.1016/j.brainresbull.2009.01.006
61. De Luca, V., Annesi, G., De Marco, E. V., De Bartolomeis, A., Nicoletti, G., Pugliese, P., et al. (2009). HOMER1 promoter analysis in Parkinson’s disease: association study with psychotic symptoms. Neuropsychobiology 59, 239–245. doi: 10.1159/000230689
62. Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S., et al. (1991). Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophr. Res. 4, 121–156. doi: 10.1016/0920-9964(91)90030-U
63. Deutch, A. Y., Ongur, D., and Duman, R. S. (1995). Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action. Neuroscience 66, 337–346. doi: 10.1016/0306-4522(94)00571-L
64. Dev, K. K. (2004). Making protein interactions druggable: targeting PDZ domains. Nat. Rev. Drug Discov. 3, 1047–1056. doi: 10.1038/nrd1578
65. Dietz, A., Buschermohle, M., Aarnisalo, A. A., Vanhanen, A., Hyyrynen, T., Aaltonen, O., et al. (2014). The development and evaluation of the finnish matrix sentence test for speech intelligibility assessment. Acta Otolaryngol. 134, 728–737. doi: 10.3109/00016489.2014.898185
66. Doyle, S., Pyndiah, S., De Gois, S., and Erickson, J. D. (2010). Excitation-transcription coupling via calcium/calmodulin-dependent protein kinase/ERK1/2 signaling mediates the coordinate induction of VGLUT2 and Narp triggered by a prolonged increase in glutamatergic synaptic activity. J. Biol. Chem. 285, 14366–14376. doi: 10.1074/jbc.M109.080069
67. Dragunow, M. (1990). Presence and induction of Fos B-like immunoreactivity in neural, but not non-neural, cells in adult rat brain. Brain Res. 533, 324–328. doi: 10.1016/0006-8993(90)91357-M
68. Durchdewald, M., Angel, P., and Hess, J. (2009). The transcription factor Fos: a Janus-type regulator in health and disease. Histol. Histopathol. 24, 1451–1461. doi: 10.14670/HH-24.1451
69. Eastwood, S. L. (2004). The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Int. Rev. Neurobiol. 59, 47–72. doi: 10.1016/S0074-7742(04)59003-7
70. Eells, J. B., Wilcots, J., Sisk, S., and Guo-Ross, S. X. (2012). NR4A gene expression is dynamically regulated in the ventral tegmental area dopamine neurons and is related to expression of dopamine neurotransmission genes. J. Mol. Neurosci. 46, 545–553. doi: 10.1007/s12031-011-9642-z
71. Ehrlich, D. E., and Josselyn, S. A. (2016). Plasticity-related genes in brain development and amygdala-dependent learning. Genes Brain Behav. 15, 125–143. doi: 10.1111/gbb.12255
72. Emsley, R., Asmal, L., Du Plessis, S., Chiliza, B., Kidd, M., Carr, J., et al. (2015). Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment. Schizophr. Res. 169, 89–94. doi: 10.1016/j.schres.2015.09.014
73. Emsley, R., Asmal, L., Du Plessis, S., Chiliza, B., Phahladira, L., and Kilian, S. (2017). Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment. Psychol. Med. 47, 2187–2196. doi: 10.1017/S0033291717000642
74. Engmann, O., Giralt, A., and Girault, J. A. (2016). Acute drug-induced spine changes in the nucleus accumbens are dependent on beta-adducin. Neuropharmacology 110, 333–342. doi: 10.1016/j.neuropharm.2016.07.035
75. Ethier, I., Beaudry, G., St-Hilaire, M., Milbrandt, J., Rouillard, C., and Levesque, D. (2004). The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression. Neuropsychopharmacology 29, 335–346. doi: 10.1038/sj.npp.1300318
76. Fernandes, A. R., and Chari, D. M. (2016). Part II: functional delivery of a neurotherapeutic gene to neural stem cells using minicircle DNA and nanoparticles: translational advantages for regenerative neurology. J. Control. Release 238, 300–310. doi: 10.1016/j.jconrel.2016.06.039
77. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179–184. doi: 10.1038/nature12929
78. Fumagalli, F., Calabrese, F., Luoni, A., Bolis, F., Racagni, G., and Riva, M. A. (2012). Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress. Int. J. Neuropsychopharmacol. 15, 235–246. doi: 10.1017/S1461145711000150
79. Fumagalli, F., Frasca, A., Racagni, G., and Riva, M. A. (2009). Antipsychotic drugs modulate Arc expression in the rat brain. Eur. Neuropsychopharmacol. 19, 109–115. doi: 10.1016/j.euroneuro.2008.09.001
80. Fumagalli, F., Molteni, R., Roceri, M., Bedogni, F., Santero, R., Fossati, C., et al. (2003). Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity. J. Neurosci. Res. 72, 622–628. doi: 10.1002/jnr.10609
81. Gangarossa, G., Di Benedetto, M., O’sullivan, G. J., Dunleavy, M., Alcacer, C., Bonito-Oliva, A., et al. (2011). Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus. PLoS ONE 6:e19415. doi: 10.1371/journal.pone.0019415.
82. Gao, C., Tronson, N. C., and Radulovic, J. (2013). Modulation of behavior by scaffolding proteins of the post-synaptic density. Neurobiol. Learn. Mem. 105, 3–12. doi: 10.1016/j.nlm.2013.04.014
83. Gao, M., Sossa, K., Song, L., Errington, L., Cummings, L., Hwang, H., et al. (2010). A specific requirement of Arc/Arg3.1 for visual experience-induced homeostatic synaptic plasticity in mouse primary visual cortex. J. Neurosci. 30, 7168–7178. doi: 10.1523/JNEUROSCI.1067-10.2010
84. Gartner, A., Polnau, D. G., Staiger, V., Sciarretta, C., Minichiello, L., Thoenen, H., et al. (2006). Hippocampal long-termpotentiation is supported by presynaptic and postsynaptic tyrosine receptor kinase B-mediated phospholipase Cgamma signaling. J. Neurosci. 26, 3496–3504. doi: 10.1523/JNEUROSCI.3792-05.2006
85. Geddes, J. R., and Miklowitz, D. J. (2013). Treatment of bipolar disorder. Lancet 381, 1672–1682. doi: 10.1016/S0140-6736(13)60857-0
86. Gentzel, R. C., Toolan, D., Roberts, R., Koser, A. J., Kandebo, M., Hershey, J., et al. (2015). The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatumand influence cataleptic behavior in rodents. Neuropharmacology 99, 256–263. doi: 10.1016/j.neuropharm.2015.05.024
87. Gerlach, R., Beck, M., Zeitschel, U., and Seifert, V. (2002). MK801 attenuates c-Fos and c-Jun expression after in vitro ischemia in rat neuronal cell cultures but not in PC 12 cells. Neurol. Res. 24, 725–729. doi: 10.1179/016164102101200654
88. Ghasemzadeh, M. B., Windham, L. K., Lake, R. W., Acker, C. J., and Kalivas, P. W. (2009). Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: differential regulation by dopamine and glutamate signaling. Synapse 63, 42–53. doi: 10.1002/syn.20577
89. Ghosh, A., Ginty, D. D., Bading, H., and Greenberg, M. E. (1994). Calcium regulation of gene expression in neuronal cells. J. Neurobiol. 25, 294–303. doi: 10.1002/neu.480250309
90. Gill, K. M., Bernstein, I. L., and Mizumori, S. J. (2007). Immediate early gene activation in hippocampus and dorsal striatum: effects of explicit place and response training. Neurobiol. Learn. Mem. 87, 583–596. doi: 10.1016/j.nlm.2006.12.011
91. Ginovart, N., and Kapur, S. (2012). Role of dopamine D(2) receptors for antipsychotic activity. Handb. Exp. Pharmacol. 212, 27–52. doi: 10.1007/978-3-642-25761-2_2
92. Gonzalez-Maeso, J., Yuen, T., Ebersole, B. J., Wurmbach, E., Lira, A., Zhou, M., et al. (2003). Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J. Neurosci. 23, 8836–8843.
93. Gonzalez-Pinto, A., Mosquera, F., Palomino, A., Alberich, S., Gutierrez, A., Haidar, K., et al. (2010). Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics. Int. Clin. Psychopharmacol. 25, 241–245. doi: 10.1097/YIC.0b013e328338bc5a
94. Grant, S. G. (2012). Synaptopathies: diseases of the synaptome. Curr. Opin. Neurobiol. 22, 522–529. doi: 10.1016/j.conb.2012.02.002
95. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153, 321–330.
96. Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., and Carr, V. J. (2011). Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol. Psychiatry 16, 960–972. doi: 10.1038/mp.2010.88
97. Grillo, R. W., Ottoni, G. L., Leke, R., Souza, D. O., Portela, L. V., and Lara, D. R. (2007). Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J. Psychiatr. Res. 41, 31–35. doi: 10.1016/j.jpsychires.2006.01.005
98. Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J. C., and Sokoloff, P. (2001). BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411, 86–89. doi: 10.1038/35075076
99. Hayashi, Y., Okamoto, K., Bosch, M., and Futai, K. (2012). Roles of neuronal activity-induced gene products in Hebbian and homeostatic synaptic plasticity, tagging, and capture. Adv. Exp. Med. Biol. 970, 335–354. doi: 10.1007/978-3-7091-0932-8_15
100. Hernandez, P. J., Schiltz, C. A., and Kelley, A. E. (2006). Dynamic shifts in corticostriatal expression patterns of the immediate early genes Homer 1a and Zif268 during early and late phases of instrumental training. Learn. Mem. 13, 599–608. doi: 10.1101/lm.335006
101. Herrera, R., Agarwal, S., Walton, K., Satterberg, B., Distel, R. J., Goodman, R., et al. (1990). A direct role for c-fos in AP-1-dependent gene transcription. Cell Growth Differ. 1, 483–490.
102. Hiroi, N., and Graybiel, A. M. (1996). Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. Comp. Neurol. 374, 70–83. doi: 10.1002/(SICI)1096-9861(19961007)374:1<70::AID-CNE5>3.0.CO;2-K
103. Ho, B. C., Andreasen, N. C., Ziebell, S., Pierson, R., and Magnotta, V. (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 68, 128–137. doi: 10.1001/archgenpsychiatry.2010.199
104. Hong, C. J., Yu, Y. W., Lin, C. H., and Tsai, S. J. (2003). An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 349, 206–208. doi: 10.1016/S0304-3940(03)00828-0
105. Hu, J. H., Park, J. M., Park, S., Xiao, B., Dehoff, M. H., Kim, S., et al. (2010). Homeostatic scaling requires group I mGluR activation mediated by Homer1a. Neuron 68, 1128–1142. doi: 10.1016/j.neuron.2010.11.008
106. Huentelman, M. J., Muppana, L., Corneveaux, J. J., Dinu, V., Pruzin, J. J., Reiman, R., et al. (2015). Association of SNPs in EGR3 and ARC with Schizophrenia supports a biological pathway for schizophrenia risk. PLoS ONE 10:e0135076. doi: 10.1371/journal.pone.0135076
107. Hughes, P., and Dragunow, M. (1995). Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47, 133–178.
108. Iasevoli, F., Ambesi-Impiombato, A., Fiore, G., Panariello, F., Muscettola, G., and De Bartolomeis, A. (2011). Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. J. Psychopharmacol. 25, 875–887. doi: 10.1177/0269881109358199
109. Iasevoli, F., Fiore, G., Cicale, M., Muscettola, G., and De Bartolomeis, A. (2010a). Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions. Psychiatry Res. 177, 255–260. doi: 10.1016/j.psychres.2010.02.009
110. Iasevoli, F., Tomasetti, C., Ambesi-Impiombato, A., Muscettola, G., and De Bartolomeis, A. (2009). Dopamine receptor subtypes contribution to Homer1a induction: insights into antipsychotic molecular action. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 813–821. doi: 10.1016/j.pnpbp.2009.02.009
111. Iasevoli, F., Tomasetti, C., and De Bartolomeis, A. (2013). Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases. Neurochem. Res. 38, 1–22. doi: 10.1007/s11064-012-0886-y
112. Iasevoli, F., Tomasetti, C., Marmo, F., Bravi, D., Arnt, J., and De Bartolomeis, A. (2010b). Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. Psychopharmacology 212, 329–344. doi: 10.1007/s00213-010-1954-0
113. Iritani, S., Niizato, K., Nawa, H., Ikeda, K., and Emson, P. C. (2003). Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 801–807. doi: 10.1016/S0278-5846(03)00112-X
114. Jarskog, L. F. (2006). Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations. Curr. Opin. Psychiatry 19, 307–312. doi: 10.1097/01.yco.0000218603.25346.8f
115. Jochum, W., Passegue, E., and Wagner, E. F. (2001). AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401–2412. doi: 10.1038/sj.onc.1204389
116. Kagaya, S., Hashida, R., Ohkura, N., Tsukada, T., Sugita, Y., Terakawa, M., et al. (2005). NR4A orphan nuclear receptor family in peripheral blood eosinophils from patients with atopic dermatitis and apoptotic eosinophils in vitro. Int. Arch. Allergy Immunol. 137(Suppl. 1), 35–44. doi: 10.1159/000085430
117. Kandel, E. R. (2001). Psychotherapy and the single synapse: the impact of psychiatric thought on neurobiological research. (1979). J. Neuropsychiatry Clin. Neurosci. 13, 290–300; discussion: 289. doi: 10.1176/jnp.13.2.290
118. Kantrowitz, J. T. (2017). Managing negative symptoms of Schizophrenia: how far have we come? CNS Drugs. 31, 373–388. doi: 10.1007/s40263-017-0428-x.
119. Katagiri, Y., Hirata, Y., Milbrandt, J., and Guroff, G. (1997). Differential regulation of the transcriptional activity of the orphan nuclear receptor NGFI-B by membrane depolarization and nerve growth factor. J. Biol. Chem. 272, 31278–31284. doi: 10.1074/jbc.272.50.31278
120. Kim, H. W., Cheon, Y., Modi, H. R., Rapoport, S. I., and Rao, J. S. (2012). Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain. Psychopharmacology 222, 663–674. doi: 10.1007/s00213-012-2671-7
121. Kimoto, S., Bazmi, H. H., and Lewis, D. A. (2014). Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am. J. Psychiatry 171, 969–978. doi: 10.1176/appi.ajp.2014.14010004
122. Kimoto, S., Zaki, M. M., Bazmi, H. H., and Lewis, D. A. (2015). Altered markers of cortical gamma-aminobutyric acid neuronal activity in Schizophrenia: role of the NARP Gene. JAMA Psychiatry 72, 747–756. doi: 10.1001/jamapsychiatry.2015.0533
123. Kontkanen, O., Lakso, M., Wong, G., and Castren, E. (2002). Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology 27, 152–162. doi: 10.1016/S0893-133X(02)00289-0
124. Kovacs, K. J., Csejtei, M., and Laszlovszky, I. (2001). Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D(3) receptor selective RGH-1756. Neuropharmacology 40, 383–393. doi: 10.1016/S0028-3908(00)00163-5
125. Lam, B. Y., Zhang, W., Enticknap, N., Haggis, E., Cader, M. Z., and Chawla, S. (2009). Inverse regulation of plasticity-related immediate early genes by calcineurin in hippocampal neurons. J. Biol. Chem. 284, 12562–12571. doi: 10.1074/jbc.M901121200
126. Lanahan, A., and Worley, P. (1998). Immediate-early genes and synaptic function. Neurobiol. Learn. Mem. 70, 37–43. doi: 10.1006/nlme.1998.3836
127. Langlois, M. C., Beaudry, G., Zekki, H., Rouillard, C., and Levesque, D. (2001). Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain. Neuroscience 106, 117–128. doi: 10.1016/S0306-4522(01)00248-2
128. Lauterborn, J. C., Rivera, S., Stinis, C. T., Hayes, V. Y., Isackson, P. J., and Gall, C. M. (1996). Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate-early gene responses fromspecific promoters. J. Neurosci. 16, 7428–7436.
129. Law, S. W., Conneely, O. M., Demayo, F. J., and O’malley, B. W. (1992). Identification of a new brain-specific transcription factor, NURR1. Mol. Endocrinol. 6, 2129–2135.
130. Leber, S. L., Llenos, I. C., Miller, C. L., Dulay, J. R., Haybaeck, J., and Weis, S. (2017). Homer1a protein expression in schizophrenia, bipolar disorder, and major depression. J. Neural. Transm. 124, 1261–1273. doi: 10.1007/s00702-017-1776-x
131. Lee, J. L. (2010). Memory reconsolidation mediates the updating of hippocampal memory content. Front. Behav. Neurosci. 4:168. doi: 10.3389/fnbeh.2010.00168
132. Lee, S. J., Wei, M., Zhang, C., Maxeiner, S., Pak, C., Calado Botelho, S., et al. (2017). Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses. J. Neurosci. 37, 1062–1080. doi: 10.1523/JNEUROSCI.2768-16.2016
133. Li, Y., Ge, S., Li, N., Chen, L., Zhang, S., Wang, J., et al. (2016). NMDA and dopamine D1 receptors within NAc-shell regulate IEG proteins expression in reward circuit during cocaine memory reconsolidation. Neuroscience 315, 45–69. doi: 10.1016/j.neuroscience.2015.11.063
134. Linden, A. M., Vaisanen, J., Lakso, M., Nawa, H., Wong, G., and Castren, E. (2000). Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents. J. Mol. Neurosci. 14, 27–37. doi: 10.1385/JMN:14:1-2:027
135. Link, W., Konietzko, U., Kauselmann, G., Krug, M., Schwanke, B., Frey, U., et al. (1995). Somatodendritic expression of an immediate early gene is regulated by synaptic activity. Proc. Natl. Acad. Sci. U.S.A. 92, 5734–5738. doi: 10.1073/pnas.92.12.5734
136. Lipska, B. K., Khaing, Z. Z., Weickert, C. S., and Weinberger, D. R. (2001). BDNF mRNAexpression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs. Eur. J. Neurosci. 14, 135–144. doi: 10.1046/j.1460-9568.2001.01633.x
137. Lonergan, M. E., Gafford, G. M., Jarome, T. J., and Helmstetter, F. J. (2010). Time-dependent expression of Arc and zif268 after acquisition of fear conditioning. Neural Plast. 2010:139891. doi: 10.1155/2010/139891
138. Lu, Y., Christian, K., and Lu, B. (2008). BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol. Learn. Mem. 89, 312–323. doi: 10.1016/j.nlm.2007.08.018
139. Luo, P., Li, X., Fei, Z., and Poon, W. (2012). Scaffold protein Homer 1: implications for neurological diseases. Neurochem. Int. 61, 731–738. doi: 10.1016/j.neuint.2012.06.014
140. Luoni, A., Fumagalli, F., Racagni, G., and Riva, M. A. (2014a). Repeated aripiprazole treatment regulates Bdnf, Arc and Npas4 expression under basal condition as well as after an acute swimstress in the rat brain. Pharmacol. Res. 80, 1–8. doi: 10.1016/j.phrs.2013.11.008
141. Luoni, A., Rocha, F. F., and Riva, M. A. (2014b). Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 50, 94–101. doi: 10.1016/j.pnpbp.2013.12.008.
142. Lyford, G. L., Yamagata, K., Kaufmann, W. E., Barnes, C. A., Sanders, L. K., Copeland, N. G., et al. (1995). Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433–445. doi: 10.1016/0896-6273(95)90299-6
143. MacGibbon, G. A., Lawlor, P. A., Bravo, R., and Dragunow, M. (1994). Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res. Mol. Brain Res. 23, 21–32. doi: 10.1016/0169-328X(94)90207-0
144. Maddox, S. A., Monsey, M. S., and Schafe, G. E. (2011). Early growth response gene 1 (Egr-1) is required for new and reactivated fear memories in the lateral amygdala. Learn. Mem. 18, 24–38. doi: 10.1101/lm.1980211
145. Maheux, J., Ethier, I., Rouillard, C., and Levesque, D. (2005). Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanismof action. J. Pharmacol. Exp. Ther. 313, 460–473. doi: 10.1124/jpet.104.080184
146. Maheux, J., Vuillier, L., Mahfouz, M., Rouillard, C., and Levesque, D. (2012). Modulation of haloperidol-induced patterns of the transcription factor Nur77 and Nor-1 expression by serotonergic and adrenergic drugs in the mouse brain. Int. J. Neuropsychopharmacol. 15, 509–521. doi: 10.1017/S1461145711000630
147. Manago, F., Mereu, M., Mastwal, S., Mastrogiacomo, R., Scheggia, D., Emanuele, M., et al. (2016). Genetic disruption of Arc/Arg3.1 in mice causes alterations in dopamine and neurobehavioral phenotypes related to schizophrenia. Cell Rep. 16, 2116–2128. doi: 10.1016/j.celrep.2016.07.044
148. Manago, F., and Papaleo, F. (2017). Schizophrenia: what’s arc got to do with it? Front. Behav. Neurosci. 11:181. doi: 10.3389/fnbeh.2017.00181
149. Mariga, A., Glaser, J., Mathias, L., Xu, D., Xiao, M., Worley, P., et al. (2015). Definition of a bidirectional activity-dependent pathway involving BDNF and Narp. Cell Rep. 13, 1747–1756. doi: 10.1016/j.celrep.2015.10.064
150. Martinez-Cengotitabengoa, M., Macdowell, K. S., Alberich, S., Diaz, F. J., Garcia-Bueno, B., Rodriguez-Jimenez, R., et al. (2016). BDNF and NGF signalling in early phases of psychosis: relationship with inflammation and response to antipsychotics after 1 year. Schizophr. Bull. 42, 142–151. doi: 10.1093/schbul/sbv078.
151. Matosin, N., Fernandez-Enright, F., Lum, J. S., Engel, M., Andrews, J. L., Gassen, N. C., et al. (2016). Molecular evidence of synaptic pathology in the CA1 region in schizophrenia. NPJ Schizophr. 2:16022. doi: 10.1038/npjschz.2016.22
152. Maxwell, M. A., and Muscat, G. E. (2006). The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl. Recept. Signal 4:e002. doi: 10.1621/nrs.04002
153. Maze, I., and Russo, S. J. (2010). Transcriptional mechanisms: underlying addiction-related structural plasticity. Mol. Interv. 10, 219–230. doi: 10.1124/mi.10.4.5
154. Menard, C., Gaudreau, P., and Quirion, R. (2015). Signaling pathways relevant to cognition-enhancing drug targets. Handb. Exp. Pharmacol. 228, 59–98. doi: 10.1007/978-3-319-16522-6_3
155. Merchant, K. M., Dobie, D. J., Filloux, F. M., Totzke, M., Aravagiri, M., and Dorsa, D. M. (1994). Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. J. Pharmacol. Exp. Ther. 271, 460–471.
156. Messaoudi, E., Kanhema, T., Soule, J., Tiron, A., Dagyte, G., Da Silva, B., et al. (2007). Sustained Arc/Arg3.1 synthesis controls long-term potentiation consolidation through regulation of local actin polymerization in the dentate gyrus in vivo. J. Neurosci. 27, 10445–10455. doi: 10.1523/JNEUROSCI.2883-07.2007
157. Meyer, D., Bonhoeffer, T., and Scheuss, V. (2014). Balance and stability of synaptic structures during synaptic plasticity. Neuron 82, 430–443. doi: 10.1016/j.neuron.2014.02.031
158. Miller, J. C. (1990). Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J. Neurochem. 54, 1453–1455. doi: 10.1111/j.1471-4159.1990.tb01983.x
159. Molteni, R., Calabrese, F., Mancini, M., Racagni, G., and Riva, M. A. (2008). Basal and stress-induced modulation of activity-regulated cytoskeletal associated protein (Arc) in the rat brain following duloxetine treatment. Psychopharmacology 201, 285–292. doi: 10.1007/s00213-008-1276-7
160. Moore, T. M., Brown, T., Cade, M., and Eells, J. B. (2008). Alterations in amphetamine-stimulated dopamine overflow due to the Nurr1-null heterozygous genotype and postweaning isolation. Synapse 62, 764–774. doi: 10.1002/syn.20550
161. Moser, M., Knoth, R., Bode, C., and Patterson, C. (2004). LE-PAS, a novel Arnt-dependent HLH-PAS protein, is expressed in limbic tissues and transactivates the CNS midline enhancer element. Brain Res. Mol. Brain Res. 128, 141–149. doi: 10.1016/j.molbrainres.2004.06.023
162. Nakahara, T., Kuroki, T., Hashimoto, K., Hondo, H., Tsutsumi, T., Motomura, K., et al. (2000). Effect of atypical antipsychotics on phencyclidine-induced expression of arc in rat brain. Neuroreport 11, 551–555. doi: 10.1097/00001756-200002280-00025
163. Nandra, K. S., and Agius, M. (2012). The differences between typical and atypical antipsychotics: the effects on neurogenesis. Psychiatr. Danub. 24(Suppl. 1), S95–S99.
164. Nestler, E. J. (2005). The neurobiology of cocaine addiction. Sci. Pract. Perspect. 3, 4–10. doi: 10.1151/spp05314
165. Nestler, E. J. (2015). FosB: a transcriptional regulator of stress and antidepressant responses. Eur. J. Pharmacol. 753, 66–72. doi: 10.1016/j.ejphar.2014.10.034
166. Neves-Pereira, M., Cheung, J. K., Pasdar, A., Zhang, F., Breen, G., Yates, P., et al. (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 10, 208–212. doi: 10.1038/sj.mp.4001575
167. Nguyen, T. V., Kosofsky, B. E., Birnbaum, R., Cohen, B. M., and Hyman, S. E. (1992). Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U.S.A. 89, 4270–4274. doi: 10.1073/pnas.89.10.4270
168. Nnadi, C. U., and Malhotra, A. K. (2007). Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics. Curr. Psychiatry Rep. 9, 313–318. doi: 10.1007/s11920-007-0038-2
169. Novak, G., Gallo, A., Zai, C. C., Meltzer, H. Y., Lieberman, J. A., Potkin, S. G., et al. (2010). Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia. Psychiatr. Genet. 20, 39–43. doi: 10.1097/YPG.0b013e3283351221
170. O’brien, R. J., Xu, D., Petralia, R. S., Steward, O., Huganir, R. L., and Worley, P. (1999). Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp. Neuron 23, 309–323. doi: 10.1016/S0896-6273(00)80782-5
171. O’brien, R., Xu, D., Mi, R., Tang, X., Hopf, C., and Worley, P. (2002). Synaptically targeted narp plays an essential role in the aggregation of AMPA receptors at excitatory synapses in cultured spinal neurons. J. Neurosci. 22, 4487–4498. doi: 20026354
172. Oda, Y., Kanahara, N., and Iyo, M. (2015). Alterations of dopamine D2 receptors and related receptor-interacting proteins in schizophrenia: the pivotal position of dopamine supersensitivity psychosis in treatment-resistant schizophrenia. Int. J. Mol. Sci. 16, 30144–30163. doi: 10.3390/ijms161226228
173. Okada, R., Fujiwara, H., Mizuki, D., Araki, R., Yabe, T., and Matsumoto, K. (2015). Involvement of dopaminergic and cholinergic systems in social isolation-induced deficits in social affiliation and conditional fear memory in mice. Neuroscience 299, 134–145. doi: 10.1016/j.neuroscience.2015.04.064
174. Openshaw, R. L., Thomson, D. M., Penninger, J. M., Pratt, J. A., and Morris, B. J. (2017). Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline. Psychopharmacology 234, 293–305. doi: 10.1007/s00213-016-4463-y
175. Ortega-Martinez, S. (2015). A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis. Front. Mol. Neurosci. 8:46. doi: 10.3389/fnmol.2015.00046
176. Ozdemir, H., Ertugrul, A., Basar, K., and Saka, E. (2012). Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 39, 62–68. doi: 10.1016/j.pnpbp.2012.05.009
177. Pang, P. T., and Lu, B. (2004). Regulation of late-phase LTPand long-termmemory in normal and aging hippocampus: role of secreted proteins tPA and BDNF. Ageing Res. Rev. 3, 407–430. doi: 10.1016/j.arr.2004.07.002
178. Panja, D., Kenney, J. W., D’andrea, L., Zalfa, F., Vedeler, A., Wibrand, K., et al. (2014). Two-stage translational control of dentate gyrus LTP consolidation is mediated by sustained BDNF-TrkB signaling to MNK. Cell Rep. 9, 1430–1445. doi: 10.1016/j.celrep.2014.10.016
179. Parikh, V., Khan, M. M., and Mahadik, S. P. (2004). Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol. Neurosci. Lett. 356, 135–139. doi: 10.1016/j.neulet.2003.10.079
180. Park, S. W., Lee, C. H., Lee, J. G., Lee, S. J., Kim, N. R., Choi, S. M., et al. (2009). Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats. J. Psychiatr. Res. 43, 274–281. doi: 10.1016/j.jpsychires.2008.05.010
181. Park, S. W., Lee, S. K., Kim, J. M., Yoon, J. S., and Kim, Y. H. (2006). Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats. Neurosci. Lett. 402, 25–29. doi: 10.1016/j.neulet.2006.03.028
182. Peebles, C. L., Yoo, J., Thwin, M. T., Palop, J. J., Noebels, J. L., and Finkbeiner, S. (2010). Arc regulates spine morphology and maintains network stability in Vivo. Proc. Natl. Acad Sci. USA 107, 18173–18178. doi: 10.1073/pnas.1006546107
183. Pei, Q., Tordera, R., Sprakes, M., and Sharp, T. (2004). Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex. Neuropharmacology 46, 331–339. doi: 10.1016/j.neuropharm.2003.09.017
184. Penke, Z., Chagneau, C., and Laroche, S. (2011). Contribution of Egr1/zif268 to activity-dependent Arc/Arg3.1 transcription in the dentate gyrus and area CA1 of the Hippocampus. Front. Behav. Neurosci. 5:48. doi: 10.3389/fnbeh.2011.00048
185. Penzes, P., Cahill, M. E., Jones, K. A., Vanleeuwen, J. E., and Woolfrey, K. M. (2011). Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285–293. doi: 10.1038/nn.2741
186. Perez-Cadahia, B., Drobic, B., and Davie, J. R. (2011). Activation and function of immediate-early genes in the nervous system. Biochem. Cell Biol. 89, 61–73. doi: 10.1139/O10-138.
187. Pillai, A., Terry, A. V. Jr., and Mahadik, S. P. (2006). Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr. Res. 82, 95–106. doi: 10.1016/j.schres.2005.11.021
188. Plath, N., Ohana, O., Dammermann, B., Errington, M. L., Schmitz, D., Gross, C., et al. (2006). Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52, 437–444. doi: 10.1016/j.neuron.2006.08.024
189. Polese, D., De Serpis, A. A., Ambesi-Impiombato, A., Muscettola, G., and De Bartolomeis, A. (2002). Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine. Neuropsychopharmacology 27, 906–913. doi: 10.1016/S0893-133X(02)00371-8
190. Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., et al. (2014). Apolygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190. doi: 10.1038/nature12975
191. Ragan, T., Kadiri, L. R., Venkataraju, K. U., Bahlmann, K., Sutin, J., Taranda, J., et al. (2012). Serial two-photon tomography for automated ex vivo mouse brain imaging. Nat. Methods 9, 255–258. doi: 10.1038/nmeth.1854
192. Raivich, G., and Behrens, A. (2006). Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog. Neurobiol. 78, 347–363. doi: 10.1016/j.pneurobio.2006.03.006
193. Renier, N., Adams, E. L., Kirst, C., Wu, Z., Azevedo, R., Kohl, J., et al. (2016). Mapping of brain activity by automated volume analysis of immediate early genes. Cell 165, 1789–1802. doi: 10.1016/j.cell.2016.05.007
194. Rex, C. S., Lauterborn, J. C., Lin, C. Y., Kramar, E. A., Rogers, G. A., Gall, C. M., et al. (2006). Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. J. Neurophysiol. 96, 677–685. doi: 10.1152/jn.00336.2006
195. Rial Verde, E. M., Lee-Osbourne, J., Worley, P. F., Malinow, R., and Cline, H. T. (2006). Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron 52, 461–474. doi: 10.1016/j.neuron.2006.09.031
196. Rinaldi, A., Mandillo, S., Oliverio, A., and Mele, A. (2007). D1 and D2 receptor antagonist injections in the prefrontal cortex selectively impair spatial learning in mice. Neuropsychopharmacology 32, 309–319. doi: 10.1038/sj.npp.1301176
197. Rizig, M. A., McQuillin, A., Ng, A., Robinson, M., Harrison, A., Zvelebil, M., et al. (2012). A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia. J. Psychopharmacol. 26, 1218–1230. doi: 10.1177/0269881112450780
198. Robbins, M. J., Critchlow, H. M., Lloyd, A., Cilia, J., Clarke, J. D., Bond, B., et al. (2008). Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study. J. Psychopharmacol. 22, 536–542. doi: 10.1177/0269881107081521
199. Robertson, G. S., and Fibiger, H. C. (1996). Effects of olanzapine on regional C-Fos expression in rat forebrain. Neuropsychopharmacology 14, 105–110. doi: 10.1016/0893-133X(95)00196-K
200. Robertson, G. S., Matsumura, H., and Fibiger, H. C. (1994). Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 271, 1058–1066.
201. Robinet, C., and Pellerin, L. (2011). Brain-derived neurotrophic factor enhances the hippocampal expression of key postsynaptic proteins in vivo including the monocarboxylate transporter MCT2. Neuroscience 192, 155–163. doi: 10.1016/j.neuroscience.2011.06.059
202. Robinet, E. A., Geurts, M., Maloteaux, J. M., and Pauwels, P. J. (2001). Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA. Neurosci. Lett. 307, 45–48. doi: 10.1016/S0304-3940(01)01923-1
203. Rodriguez, J. J., Garcia, D. R., Nakabeppu, Y., and Pickel, V. M. (2001). FosB in rat striatum: normal regional distribution and enhanced expression after 6-month haloperidol administration. Synapse 39, 122–132. doi: 10.1002/1098-2396(200102)39:2<122::AID-SYN3>3.0.CO;2-R
204. Rojas, P., Joodmardi, E., Hong, Y., Perlmann, T., and Ogren, S. O. (2007). Adult mice with reduced Nurr1 expression: an animal model for schizophrenia. Mol. Psychiatry 12, 756–766. doi: 10.1038/sj.mp.4001993
205. Sakuma, K., Komatsu, H., Maruyama, M., Imaichi, S., Habata, Y., and Mori, M. (2015). Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain. PLoS ONE 10:e0118510. doi: 10.1371/journal.pone.0118510
206. Samaha, A. N., Reckless, G. E., Seeman, P., Diwan, M., Nobrega, J. N., and Kapur, S. (2008). Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery. Biol. Psychiatry 64, 145–152. doi: 10.1016/j.biopsych.2008.01.010
207. Saunderson, E. A., Spiers, H., Mifsud, K. R., Gutierrez-Mecinas, M., Trollope, A. F., Shaikh, A., et al. (2016). Stress-induced gene expression and behavior are controlled by DNA methylation and methyl donor availability in the dentate gyrus. Proc. Natl. Acad. Sci. U.S.A. 113, 4830–4835. doi: 10.1073/pnas.1524857113
208. Sauvage, M. M., Nakamura, N. H., and Beer, Z. (2013). Mapping memory function in the medial temporal lobe with the immediate-early gene Arc. Behav. Brain Res. 254, 22–33. doi: 10.1016/j.bbr.2013.04.048
209. Schubert, K. O., Focking, M., Wynne, K., and Cotter, D. R. (2016). Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus. Proteomics 16, 532–538. doi: 10.1002/pmic.201500242
210. Seeman, M. V., and Seeman, P. (2014). Is schizophrenia a dopamine supersensitivity psychotic reaction? Prog. Neuropsychopharmacol. Biol. Psychiatry 48, 155–160. doi: 10.1016/j.pnpbp.2013.10.003
211. Seeman, P. (2002). Atypical antipsychotics: mechanismof action. Can. J. Psychiatry 47, 27–38. doi: 10.1177/070674370204700106
212. Semba, J., Sakai, M. W., Suhara, T., and Akanuma, N. (1999). Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization. Neurochem. Int. 34, 269–277. doi: 10.1016/S0197-0186(99)00009-1
213. Serchov, T., Heumann, R., Van Calker, D., and Biber, K. (2016). Signaling pathways regulating Homer1a expression: implications for antidepressant therapy. Biol. Chem. 397, 207–214. doi: 10.1515/hsz-2015-0267
214. Shamloo, M., Soriano, L., Von Schack, D., Rickhag, M., Chin, D. J., Gonzalez-Zulueta, M., et al. (2006). Npas4, a novel helix-loop-helix PAS domain protein, is regulated in response to cerebral ischemia. Eur. J. Neurosci. 24, 2705–2720. doi: 10.1111/j.1460-9568.2006.05172.x
215. Shen, X., Purser, C., Tien, L. T., Chiu, C. T., Paul, I. A., Baker, R., et al. (2010). mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization. J. Neurosci. Res. 88, 2294–2302. doi: 10.1002/jnr.22386
216. Shepard, R., Heslin, K., and Coutellier, L. (2017). The transcription factor Npas4 contributes to adolescent development of prefrontal inhibitory circuits, and to cognitive and emotional functions: implications for neuropsychiatric disorders. Neurobiol. Dis. 99, 36–46. doi: 10.1016/j.nbd.2016.12.012
217. Shin, S. M., Zhang, N., Hansen, J., Gerges, N. Z., Pak, D. T., Sheng, M., et al. (2012). GKAPorchestrates activity-dependent postsynaptic proteinremodeling and homeostatic scaling. Nat. Neurosci. 15, 1655–1666. doi: 10.1038/nn.3259
218. Shiraishi-Yamaguchi, Y., and Furuichi, T. (2007). The homer family proteins. Genome Biol. 8:206. doi: 10.1186/gb-2007-8-2-206
219. Shirayama, Y., Hashimoto, K., Matsuki, H., Tsunashima, K., Iyo, M., Higuchi, T., et al. (1999). Increased expression of zif268 mRNA in rat retrosplenial cortex following administration of phencyclidine. Brain Res. 839, 180–185. doi: 10.1016/S0006-8993(99)01738-2
220. Snyder, J. S., Clifford, M. A., Jeurling, S. I., and Cameron, H. A. (2012). Complementary activation of hippocampal-cortical subregions and immature neurons following chronic training in single and multiple context versions of the water maze. Behav. Brain Res. 227, 330–339. doi: 10.1016/j.bbr.2011. 06.025
221. Spellmann, I., Rujescu, D., Musil, R., Mayr, A., Giegling, I., Genius, J., et al. (2011). Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients. J. Psychiatr. Res. 45, 234–241. doi: 10.1016/j.jpsychires.2010.06.004
222. Srivas, S., and Thakur, M. K. (2016). Epigenetic regulation of neuronal immediate early genes is associated with decline in their expression and memory consolidation in scopolamine-induced amnesic mice. Mol. Neurobiol. 54, 5107–5119. doi: 10.1007/s12035-016-0047-4
223. Steward, O., Farris, S., Pirbhoy, P. S., Darnell, J., and Driesche, S. J. (2014). Localization and local translation of Arc/Arg3.1 mRNA at synapses: some observations and paradoxes. Front. Mol. Neurosci. 7:101. doi: 10.3389/fnmol.2014.00101.
224. Steward, O., and Worley, P. F. (2001). A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites. Proc. Natl. Acad. Sci. U.S.A. 98, 7062–7068. doi: 10.1073/pnas.131146398
225. Szumlinski, K. K., Abernathy, K. E., Oleson, E. B., Klugmann, M., Lominac, K. D., He, D. Y., et al. (2006). Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology 31, 768–777. doi: 10.1038/sj.npp.1300890
226. Szumlinski, K. K., Dehoff, M. H., Kang, S. H., Frys, K. A., Lominac, K. D., Klugmann, M., et al. (2004). Homer proteins regulate sensitivity to cocaine. Neuron 43, 401–413. doi: 10.1016/j.neuron.2004.07.019
227. Szumlinski, K. K., Lominac, K. D., Kleschen, M. J., Oleson, E. B., Dehoff, M. H., Schwarz, M. K., et al. (2005). Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav. 4, 273–288. doi: 10.1111/j.1601-183X.2005.00120.x
228. Takahashi, T., Suzuki, M., Tsunoda, M., Kawamura, Y., Takahashi, N., Tsuneki, H., et al. (2008). Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci. Lett. 435, 34–39. doi: 10.1016/j.neulet.2008.02.004
229. Tan, Y. L., Zhou, D. F., Cao, L. Y., Zou, Y. Z., and Zhang, X. Y. (2005). Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci. Lett. 382, 27–32. doi: 10.1016/j.neulet.2005.02.054
230. Tetradis, S., Bezouglaia, O., Tsingotjidou, A., and Vila, A. (2001). Regulation of the nuclear orphan receptor Nur77 in bone by parathyroid hormone. Biochem. Biophys. Res. Commun. 281, 913–916. doi: 10.1006/bbrc.2001.4459
231. Tien, L. T., Ho, I. K., and Ma, T. (2010). Methamphetamine-induced expression of zif268 mRNA is prevented by haloperidol in mice lacking mu-opioid receptor. Neurotoxicology 31, 326–330. doi: 10.1016/j.neuro.2010.02.002
232. Tomasetti, C., Dell’aversano, C., Iasevoli, F., and De Bartolomeis, A. (2007). Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action. Neuroscience 150, 144–158. doi: 10.1016/j.neuroscience.2007.08.022
233. Tomasetti, C., Dell’aversano, C., Iasevoli, F., Marmo, F., and De Bartolomeis, A. (2011). The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 184–197. doi: 10.1016/j.pnpbp.2010.10.025
234. Tost, H., Braus, D. F., Hakimi, S., Ruf, M., Vollmert, C., Hohn, F., et al. (2010). Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nat. Neurosci. 13, 920–922. doi: 10.1038/nn.2572
235. Tsui, C. C., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Barnes, C., and Worley, P. F. (1996). Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J. Neurosci. 16, 2463–2478.
236. Vahid-Ansari, F., Nakabeppu, Y., and Robertson, G. S. (1996). Contrasting effects of chronic clozapine, Seroquel(TM) (ICI 204,636) and haloperidol administration of deltaFosB-like immunoreactivity in the rodent forebrain. Eur. J. Neurosci. 8, 927–936. doi: 10.1111/j.1460-9568.1996.tb01579.x
237. Valenti, O., and Grace, A. A. (2010). Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway. Int. J. Neuropsychopharmacol. 13, 845–860. doi: 10.1017/S1461145709990599
238. Vazdarjanova, A., McNaughton, B. L., Barnes, C. A., Worley, P. F., and Guzowski, J. F. (2002). Experience-dependent coincident expression of the effector immediate-early genes arc and Homer 1a in hippocampal and neocortical neuronal networks. J. Neurosci. 22, 10067–10071.
239. Verma, V., Lim, E. P., Han, S. P., Nagarajah, R., and Dawe, G. S. (2007). Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex. Neurosci. Res. 57, 17–28. doi: 10.1016/j.neures.2006.09.002
240. Verma, V., Rasmussen, K., and Dawe, G. S. (2006). Effects of short-term and chronic olanzapine treatment on immediate early gene protein and tyrosine hydroxylase immunoreactivity in the rat locus coeruleus and medial prefrontal cortex. Neuroscience 143, 573–585. doi: 10.1016/j.neuroscience.2006. 08.010
241. Vita, A., De Peri, L., Deste, G., Barlati, S., and Sacchetti, E. (2015). The Effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies. Biol. Psychiatry 78, 403–412. doi: 10.1016/j.biopsych.2015.02.008
242. Waller, J. A., Tamm, J. A., Abdourahman, A., Pehrson, A. L., Li, Y., Cajina, M., et al. (2017). Chronic vortioxetine treatment in rodents modulates gene expression of neurodevelopmental and plasticity markers. Eur. Neuropsychopharmacol. 27, 192–203. doi: 10.1016/j.euroneuro.2016.11.014
243. Wang, H. X., and Gao, W. J. (2012). Prolonged exposure to NMDAR antagonist induces cell-type specific changes of glutamatergic receptors in rat prefrontal cortex. Neuropharmacology 62, 1808–1822. doi: 10.1016/j.neuropharm.2011.11.024
244. Waterhouse, E. G., and Xu, B. (2009). New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol. Cell. Neurosci. 42, 81–89. doi: 10.1016/j.mcn.2009.06.009
245. Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., and Kleinman, J. E. (2003). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 8, 592–610. doi: 10.1038/sj.mp.4001308
246. Weinberger, D. R., and Berman, K. F. (1996). Prefrontal function in schizophrenia: confounds and controversies. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351, 1495–1503. doi: 10.1098/rstb.1996.0135
247. Werme, M., Ringholm, A., Olson, L., and Brene, S. (2000). Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res. 863, 112–119. doi: 10.1016/S0006-8993(00)02109-0
248. Wheeler, A. L., Creed, M. C., Voineskos, A. N., and Nobrega, J. N. (2014). Changes in brain functional connectivity after chronic haloperidol in rats: a network analysis. Int. J. Neuropsychopharmacol. 17, 1129–1138. doi: 10.1017/S1461145714000042
249. White, N. M., and Hiroi, N. (1998). Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum. Proc. Natl. Acad. Sci. U.S.A. 95, 6486–6491. doi: 10.1073/pnas.95.11.6486
250. Wibrand, K., Pai, B., Siripornmongcolchai, T., Bittins, M., Berentsen, B., Ofte, M. L., et al. (2012). MicroRNA regulation of the synaptic plasticity-related gene Arc. PLoS ONE 7:e41688. doi: 10.1371/journal.pone.0041688
251. Wiig, K. A., Whitlock, J. R., Epstein, M. H., Carpenter, R. L., and Bear, M. F. (2009). The levo enantiomer of amphetamine increases memory consolidation and gene expressioninthe hippocampus without producing locomotor stimulation. Neurobiol. Learn. Mem. 92, 106–113. doi: 10.1016/j.nlm.2009.02.001
252. Xie, H., Liu, Y., Zhu, Y., Ding, X., Yang, Y., and Guan, J. S. (2014). In vivo imaging of immediate early gene expression reveals layer-specific memory traces in the mammalian brain. Proc. Natl. Acad. Sci. U.S.A. 111, 2788–2793. doi: 10.1073/pnas.1316808111
253. Xing, G., Zhang, L., Russell, S., and Post, R. (2006). Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophr. Res. 84, 36–56. doi: 10.1016/j.schres.2005.11.006
254. Xu, B., Gottschalk, W., Chow, A., Wilson, R. I., Schnell, E., Zang, K., et al. (2000). The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanisminvolving TrkB. J. Neurosci. 20, 6888–6897.
255. Yamada, H., Kuroki, T., Nakahara, T., Hashimoto, K., Tsutsumi, T., Hirano, M., et al. (2007). The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens. Brain Res. 1131, 88–96. doi: 10.1016/j.brainres.2006.11.011
256. Yano, H., Ninan, I., Zhang, H., Milner, T. A., Arancio, O., and Chao, M. V. (2006). BDNF-mediated neurotransmission relies upon a myosin VI motor complex. Nat. Neurosci. 9, 1009–1018. doi: 10.1038/nn1730
257. Yano, M., and Steiner, H. (2005). Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132, 855–865. doi: 10.1016/j.neuroscience.2004.12.019
258. Yin, D. M., Chen, Y. J., Sathyamurthy, A., Xiong, W. C., and Mei, L. (2012). Synaptic dysfunction in schizophrenia. Adv. Exp. Med. Biol. 970, 493–516. doi: 10.1007/978-3-7091-0932-8_22
259. Young, C. D., Meltzer, H. Y., and Deutch, A. Y. (1998). Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite. Neuropsychopharmacology 19, 99–103. doi: 10.1016/S0893-133X(97)00203-0
260. Yue, Y., Kong, L., Wang, J., Li, C., Tan, L., Su, H., et al. (2016). Regional abnormality of grey matter in schizophrenia: effect fromthe illness or treatment? PLoS ONE 11:e0147204. doi: 10.1371/journal.pone.0147204
261. Zai, C. C., Tiwari, A. K., De Luca, V., Muller, D. J., Bulgin, N., Hwang, R., et al. (2009). Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia. Eur. Neuropsychopharmacol. 19, 317–328. doi: 10.1016/j.euroneuro.2009.01.001
262. Zhang, G. C., Mao, L. M., Liu, X. Y., Parelkar, N. K., Arora, A., Yang, L., et al. (2007). In vivo regulation of Homer1a expression in the striatum by cocaine. Mol. Pharmacol. 71, 1148–1158. doi: 10.1124/mol.106.028399
263. Zhang, W., Wu, J., Ward, M. D., Yang, S., Chuang, Y. A., Xiao, M., et al. (2015). Structural basis of arc binding to synaptic proteins: implications for cognitive disease. Neuron 86, 490–500. doi: 10.1016/j.neuron.2015.03.030
264. Zhang, X. Y., Chen, D. C., Tan, Y. L., Tan, S. P., Luo, X., Zuo, L., et al. (2016). BDNF polymorphisms are associated with schizophrenia onset and positive symptoms. Schizophr. Res. 170, 41–47. doi: 10.1016/j.schres.2015.11.009
265. Zhou, X., Moon, C., Zheng, F., Luo, Y., Soellner, D., Nunez, J. L., et al. (2009). N-methyl-D-aspartate-stimulated ERK1/2 signaling and the transcriptional up-regulation of plasticity-related genes are developmentally regulated following in vitro neuronal maturation. J. Neurosci. Res. 87, 2632–2644. doi: 10.1002/jnr.22103